Cargando…

Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study

BACKGROUND: Data from population-based cancer registries are often used to compare cancer survival between countries or regions. The ICBP SURVMARK-2 study is an international partnership aiming to quantify and explore the reasons behind survival differences across high-income countries. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersson, Therese M.-L., Rutherford, Mark J., Myklebust, Tor Åge, Møller, Bjørn, Soerjomataram, Isabelle, Arnold, Melina, Bray, Freddie, Parkin, D. Max, Sasieni, Peter, Bucher, Oliver, De, Prithwish, Engholm, Gerda, Gavin, Anna, Little, Alana, Porter, Geoff, Ramanakumar, Agnihotram V., Saint-Jacques, Nathalie, Walsh, Paul M., Woods, Ryan R., Lambert, Paul C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921088/
https://www.ncbi.nlm.nih.gov/pubmed/33293692
http://dx.doi.org/10.1038/s41416-020-01196-7
_version_ 1783658405059100672
author Andersson, Therese M.-L.
Rutherford, Mark J.
Myklebust, Tor Åge
Møller, Bjørn
Soerjomataram, Isabelle
Arnold, Melina
Bray, Freddie
Parkin, D. Max
Sasieni, Peter
Bucher, Oliver
De, Prithwish
Engholm, Gerda
Gavin, Anna
Little, Alana
Porter, Geoff
Ramanakumar, Agnihotram V.
Saint-Jacques, Nathalie
Walsh, Paul M.
Woods, Ryan R.
Lambert, Paul C.
author_facet Andersson, Therese M.-L.
Rutherford, Mark J.
Myklebust, Tor Åge
Møller, Bjørn
Soerjomataram, Isabelle
Arnold, Melina
Bray, Freddie
Parkin, D. Max
Sasieni, Peter
Bucher, Oliver
De, Prithwish
Engholm, Gerda
Gavin, Anna
Little, Alana
Porter, Geoff
Ramanakumar, Agnihotram V.
Saint-Jacques, Nathalie
Walsh, Paul M.
Woods, Ryan R.
Lambert, Paul C.
author_sort Andersson, Therese M.-L.
collection PubMed
description BACKGROUND: Data from population-based cancer registries are often used to compare cancer survival between countries or regions. The ICBP SURVMARK-2 study is an international partnership aiming to quantify and explore the reasons behind survival differences across high-income countries. However, the magnitude and relevance of differences in cancer survival between countries have been questioned, as it is argued that observed survival variations may be explained, at least in part, by differences in cancer registration practice, completeness and the availability and quality of the respective data sources. METHODS: As part of the ICBP SURVMARK-2 study, we used a simulation approach to better understand how differences in completeness, the characteristics of those missed and inclusion of cases found from death certificates can impact on cancer survival estimates. RESULTS: Bias in 1- and 5-year net survival estimates for 216 simulated scenarios is presented. Out of the investigated factors, the proportion of cases not registered through sources other than death certificates, had the largest impact on survival estimates. CONCLUSION: Our results show that the differences in registration practice between participating countries could in our most extreme scenarios explain only a part of the largest observed differences in cancer survival.
format Online
Article
Text
id pubmed-7921088
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79210882021-03-12 Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study Andersson, Therese M.-L. Rutherford, Mark J. Myklebust, Tor Åge Møller, Bjørn Soerjomataram, Isabelle Arnold, Melina Bray, Freddie Parkin, D. Max Sasieni, Peter Bucher, Oliver De, Prithwish Engholm, Gerda Gavin, Anna Little, Alana Porter, Geoff Ramanakumar, Agnihotram V. Saint-Jacques, Nathalie Walsh, Paul M. Woods, Ryan R. Lambert, Paul C. Br J Cancer Article BACKGROUND: Data from population-based cancer registries are often used to compare cancer survival between countries or regions. The ICBP SURVMARK-2 study is an international partnership aiming to quantify and explore the reasons behind survival differences across high-income countries. However, the magnitude and relevance of differences in cancer survival between countries have been questioned, as it is argued that observed survival variations may be explained, at least in part, by differences in cancer registration practice, completeness and the availability and quality of the respective data sources. METHODS: As part of the ICBP SURVMARK-2 study, we used a simulation approach to better understand how differences in completeness, the characteristics of those missed and inclusion of cases found from death certificates can impact on cancer survival estimates. RESULTS: Bias in 1- and 5-year net survival estimates for 216 simulated scenarios is presented. Out of the investigated factors, the proportion of cases not registered through sources other than death certificates, had the largest impact on survival estimates. CONCLUSION: Our results show that the differences in registration practice between participating countries could in our most extreme scenarios explain only a part of the largest observed differences in cancer survival. Nature Publishing Group UK 2020-12-09 2021-03-02 /pmc/articles/PMC7921088/ /pubmed/33293692 http://dx.doi.org/10.1038/s41416-020-01196-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Andersson, Therese M.-L.
Rutherford, Mark J.
Myklebust, Tor Åge
Møller, Bjørn
Soerjomataram, Isabelle
Arnold, Melina
Bray, Freddie
Parkin, D. Max
Sasieni, Peter
Bucher, Oliver
De, Prithwish
Engholm, Gerda
Gavin, Anna
Little, Alana
Porter, Geoff
Ramanakumar, Agnihotram V.
Saint-Jacques, Nathalie
Walsh, Paul M.
Woods, Ryan R.
Lambert, Paul C.
Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study
title Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study
title_full Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study
title_fullStr Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study
title_full_unstemmed Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study
title_short Exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study
title_sort exploring the impact of cancer registry completeness on international cancer survival differences: a simulation study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921088/
https://www.ncbi.nlm.nih.gov/pubmed/33293692
http://dx.doi.org/10.1038/s41416-020-01196-7
work_keys_str_mv AT anderssonthereseml exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT rutherfordmarkj exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT myklebusttorage exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT møllerbjørn exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT soerjomataramisabelle exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT arnoldmelina exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT brayfreddie exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT parkindmax exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT sasienipeter exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT bucheroliver exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT deprithwish exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT engholmgerda exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT gavinanna exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT littlealana exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT portergeoff exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT ramanakumaragnihotramv exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT saintjacquesnathalie exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT walshpaulm exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT woodsryanr exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy
AT lambertpaulc exploringtheimpactofcancerregistrycompletenessoninternationalcancersurvivaldifferencesasimulationstudy